Plasma Concentration of Biological Markers in Placenta Accreta Spectrum
Plasma Concentration of Biological Markers in Placenta Spectrum
Sponsor: University of Arkansas
Terminated
difficulties with enrollment
A observational or N/A phase clinical study on Placenta Accreta and Placenta Diseases, this trial is terminated or withdrawn. The trial is conducted by University of Arkansas and has accumulated 18 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
18 versions recorded-
Oct 2024 — Present [monthly]
Terminated
-
Sep 2024 — Oct 2024 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2023 — Jul 2024 [monthly]
Terminated
-
Sep 2023 — Dec 2023 [monthly]
Terminated
Status: Suspended → Terminated
▶ Show 13 earlier versions
-
Aug 2023 — Sep 2023 [monthly]
Suspended
Status: Recruiting → Suspended
-
Jun 2023 — Aug 2023 [monthly]
Recruiting
-
Feb 2023 — Jun 2023 [monthly]
Recruiting
Status: Completed → Recruiting
-
Dec 2022 — Feb 2023 [monthly]
Completed
Status: Suspended → Completed
-
Sep 2022 — Dec 2022 [monthly]
Suspended
Status: Recruiting → Suspended
-
Jul 2022 — Sep 2022 [monthly]
Recruiting
-
Jan 2022 — Jul 2022 [monthly]
Recruiting
-
Dec 2021 — Jan 2022 [monthly]
Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Sep 2020 — Oct 2020 [monthly]
Not Yet Recruiting
First recorded
Aug 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Arkansas
For direct contact, visit the study record on ClinicalTrials.gov .